Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about ARVN
Recent news which mentions ARVN
< Previous
1
2
3
4
Next >
Where Arvinas Stands With Analysts
September 09, 2022
Tickers
ARVN
Tags
Market News
Analyst Ratings
ARVN
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Tickers
ADCT
ALEC
ANNX
ARVN
Tags
ZUMZ
Upgrades
WTRG
From
Benzinga
Expert Ratings for Arvinas
September 09, 2022
Tickers
ARVN
Tags
Analyst Ratings
Market News
ARVN
From
Benzinga
Arvinas's Return on Invested Capital Insights
August 22, 2022
Tickers
ARVN
Tags
Benzinga
ARVN
BZI/ROCE
From
Benzinga
Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock
August 18, 2022
Tickers
ARVN
SNY
Tags
Benzinga
Analyst Ratings
General
From
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Tickers
A
AACG
ABBV
AKU
Tags
Movers From Yesterday
SPRO
NVAX
From
Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
August 17, 2022
Tickers
ARVN
BPMC
CVNA
DNUT
Tags
ARVN
UPST
SE
From
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Tickers
A
AACG
ABBV
AKU
Tags
ITRM
FPAY
ZIP
From
Benzinga
8 Analysts Have This to Say About Arvinas
August 08, 2022
Tickers
ARVN
Tags
BZI/AAR
ARVN
Market News
From
Benzinga
Recap: Arvinas Q2 Earnings
August 04, 2022
Tickers
ARVN
Tags
BZI/Recaps
ARVN
Market News
From
Benzinga
7 Analysts Have This to Say About Arvinas
June 21, 2022
Tickers
ARVN
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022
June 21, 2022
Tickers
ABM
ADBE
AMT
AOUT
Tags
HYLN
SYM
LSI
From
Benzinga
Analyst Ratings for Arvinas
May 20, 2022
Tickers
ARVN
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
May 09, 2022
Tickers
AIRC
APLD
ARVN
ATNF
Tags
Downgrades
SFNC
TFX
From
Benzinga
Arvinas: Q1 Earnings Insights
May 05, 2022
Tickers
ARVN
Tags
News
Benzinga
Earnings
From
Benzinga
What 6 Analyst Ratings Have To Say About Arvinas
April 28, 2022
Tickers
ARVN
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
VRM
Downgrades
XERS
From
Benzinga
Expert Ratings For Arvinas
April 06, 2022
Tickers
ARVN
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
April 06, 2022
Tickers
ABMD
AMP
APTV
ARRY
Tags
AMP
PYPL
UCBI
From
Benzinga
Arvinas Earnings Perspective: Return On Capital Employed
March 01, 2022
Tickers
ARVN
Tags
ARVN
BZI/ROCE
Earnings
From
Benzinga
Where Arvinas Stands With Analysts
March 01, 2022
Tickers
ARVN
Tags
Benzinga
Market News
Analyst Ratings
From
Benzinga
Arvinas: Q4 Earnings Insights
February 28, 2022
Tickers
ARVN
Tags
Benzinga
News
BZI/Recaps
From
Benzinga
3 Stocks To Double Down On In 2022
February 16, 2022
Tickers
ARVN
BBWI
VTEX
Tags
VTEX
BBWI
ARVN
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
BIIB
PFE
SNY
From
Motley Fool
Arvinas Highlights New ARV-110 Data In Prostate Cancer Patients
February 15, 2022
Tickers
ARVN
Tags
News
Trading Ideas
Health Care
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
Tickers
AIG
AMBA
ARVN
AXP
Tags
THC
QMCO
BURL
From
Benzinga
2 Exciting Trends That Could Shape Healthcare's Future
February 10, 2022
Tickers
ARVN
BEAM
CCCC
CRSP
Tags
KYMR
BEAM
ARVN
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
January 19, 2022
Tickers
ABB
ADSE
AKAM
ALLY
Tags
XOM
ATVI
CMPX
From
Benzinga
5 Stocks Insiders Are Selling
December 17, 2021
Tickers
AEE
ARVN
HPE
LZ
Tags
ARVN
Benzinga
Insider Trades
From
Benzinga
Arvinas, Pfizer's ARV-471 Shows Clinical Benefit Rate Of 40% In Pretreated Breast Cancer Patients
December 10, 2021
Tickers
ARVN
PFE
Tags
Market News
Briefs
PFE
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.